VKTX 241206 49.00C (VKTX241206C49000) Stock Options, News & Quotes

US OptionsDetailed Quotes

VKTX241206C49000

Watchlist

2.90
-0.70-19.44%

15min DelayClose Dec 3 16:00 ET

2.90High2.90Low

Intraday

5D
Daily

News

Express News | 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
Benzinga12:11 ET
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
Yahoo FinanceDec 3 08:27 ET
Corbus, Viking Initiated at Overweight by Piper Sandler
Seeking AlphaDec 2 13:34 ET
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BenzingaDec 2 08:56 ET
Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74
BenzingaDec 2 05:48 ET · Ratings
Piper Sandler Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $74
Moomoo NewsDec 2 05:34 ET · Ratings

Comments

72792912

4 hours ago

$Viking Therapeutics (VKTX.US)$ don’t worry. VK2809 is enough to support the price of this stock to reach 100 and even higher

Dannymite

4 hours ago

It seems like going to a major downfall, it's about to hit the support point and heading to a "death cross".

$Viking Therapeutics (VKTX.US)$

Hanh Tran384

7 hours ago

Can anyone tell me what is going on with VKTX now?? It is keep falling down even after good news?? 🥲

$Viking Therapeutics (VKTX.US)$

Shaaaw

Nov 27 06:52

Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...

102875548

Nov 26 08:53

$Viking Therapeutics (VKTX.US)$
🚀🚀🚀🚀 now all engines firing